Taken together, our findings reveal the regulatory mechanism of NEAT1 in β-amyloid deposition, which has significant implications for the aetiology of AD and may provide a new intervention target for preventing or delaying the occurrence of AD. This evidence concerns the gene NEAT1 and Alzheimer disease.